"This in effect will facilitate high-throughput screening of patients at resource constrained or remotely located healthcare centers lacking even minimal access to expert physicians, but witnessing an exponential rise in deaths related to complex skin abnormalities," Sheet said.
The app will not only help in diagnosis but also monitoring the control of the disease.
"We will sell it to hospital chains and healthcare service providers in India," he said.
It can also be used in countries like Africa where health infrastructure is very poor.
On the accuracy of the product, the researcher said tests have found it to be 99 per cent accurate.
Updated on: December 22, 2013 15:52 IST
